News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Biopharmaceutical Leaders Announce New Effort to…
Today more than 20 leading biopharmaceutical companies announced the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as the threat of antimicrobial resistance, or…
BIO Impact Goes Fully Digital for 2020
Washington, D.C. (July 8, 2020)—The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO IMPACT Ag & Environment Conference scheduled for September 21-22 to an online platform, instead of convening an in…
Biotech Innovation Will Play Key Role in Solving…
Congressional Action Plan Released Today Incorporates Key BIO Recommendations Washington, D.C. (June 30, 2020) – Cleaner air, healthier soils, and improved human health – goals of a Congressional climate crisis action plan released today – are just…
Letters, Testimony, & Comments
Orphan Drugs: BIO Comments on Interpreting…
The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to submit comments on the Draft Guidance for Industry “Interpreting Sameness of Gene Therapy Products Under the Orphan Drug…
Congressional Black Caucus and Congressional…
We are writing regarding the proposed 2018 Renewable Volume Obligation under the RFS. Rather than support continued growth in the lowest carbon types of biofuels under the statue, your proposal reduces the blending target for cellulosic biofuels and…
Congressional Black Caucus Letter to EPA on RFS…
As you finalize the proposed rules under the Renewable Fuel Standard, we respectfully urge you to not reduce the biofuels volume requirements. The RFS program has helped the environment, our economy, and has increased our confidence in renewable…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
A herd of cows on a farm
July 10, 2020
Have you seen the headlines lately? Between the milestone and record-setting three million cases of coronavirus in the United States, the new strain of swine flu “with human pandemic potential,” and the sudden…
Industrial plant
July 2, 2020
In a National Academies webinar, former Secretary of Agriculture Tom Vilsack said, we as a nation have to consider that resiliency is just as important as efficiency. He was talking about the ways in which the…
Solving the Climate Crisis Report
July 2, 2020
As Congressional Democrats promote their climate crisis action plan, BIO is pointing to the role of biotech innovation in achieving the goals of cleaner air, healthier soils, improved human health, and a strengthened…